Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026)
Rockwell Medical (RMTI) posted Cash from Investing Activities of -$122000.0 for Q1 2026, up 97.05% on a QoQ basis from -$4.1 million in Q4 2025, and down 12100.0% year-over-year from N/an in Q1 2025.
Rockwell Medical (RMTI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Rockwell Medical's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$122000.0 for Q1 2026.
- Quarterly Cash from Investing Activities fell 12100.0% year-over-year to -$122000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.7 million (down 83.27% YoY) and the FY2025 annual result came in at -$8.5 million, down 75.59% from the prior year.
- Cash from Investing Activities was -$122000.0 for Q1 2026 at Rockwell Medical, up from -$4.1 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $9.1 million in Q1 2022 and bottomed at -$14.7 million in Q3 2022.
- A 5-year average of -$1.1 million and a median of -$103000.0 in 2025 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 2782.81% — and 2026, when it plunged 12100.0%.
- Rockwell Medical's Cash from Investing Activities stood at $3.2 million in 2022, then slumped by 37.6% to $2.0 million in 2023, then plunged by 116.53% to -$332000.0 in 2024, then tumbled by 1144.28% to -$4.1 million in 2025, then jumped by 97.05% to -$122000.0 in 2026.
- Business Quant data shows RMTI's Cash from Investing Activities at -$122000.0 in Q1 2026, -$4.1 million in Q4 2025, and -$4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Rockwell Medical | 27.99 Mn | 4.10 Mn | 2.90 Mn | -122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -4.13 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | -6.11 Mn |
| Sep 30, 2024 | -6.11 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | -139,000.00 |
| Mar 31, 2024 | -139,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |